Zealand Pharma AS (ZLDPF)
114.46
+1.61
(+1.43%)
USD |
OTCM |
Dec 16, 15:40
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 8.086B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 123.2% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 651.46 |
| Price to Book Value | 6.077 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0316 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 74.12% |
Profile
| Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. Its products include soliqua 100/33/suliqua and adlyxin. The firm focuses on gastrointestinal diseases and metabolic diseases. Its product pipeline includes dasiglucagon, glepaglutide, and dual glucagon product candidates. |
| URL | https://www.zealandpharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Feb. 20, 2025 |
| Last Earnings Release | Nov. 07, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. Its products include soliqua 100/33/suliqua and adlyxin. The firm focuses on gastrointestinal diseases and metabolic diseases. Its product pipeline includes dasiglucagon, glepaglutide, and dual glucagon product candidates. |
| URL | https://www.zealandpharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Feb. 20, 2025 |
| Last Earnings Release | Nov. 07, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |